SOURCE: Solos Endoscopy, Inc.

December 06, 2007 08:31 ET

Solos Endoscopy, Inc. CEO Is Featured on Audio Interview

BOSTON, MA--(Marketwire - December 6, 2007) - Solos Endoscopy, Inc. (PINKSHEETS: SLSY) announced today that CEO Bob Segersten is featured on is a multimedia investor relations source that gives attention to promising companies that seek an economical approach to more exposure in the investor community.

Mr. Segersten will discuss some details of current company developments for the benefit of shareholders and prospective investors, as well as his outlook for 2008.

"At Solos, excellence is not an option," stated CEO Bob Segersten. "Our commitment is to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic solutions."

The Company recently announced that since uses the "information highway" to give promising companies a cost-effective way to reach more prospective investors, Solos will utilize as a means to obtain more exposure via the Internet.

About differentiates itself from traditional IR firms, in that we strive to take a long-term approach of nurturing and supporting the expansion of emerging companies that aspire to grow and appreciate in value. Through exposure on the World Wide Web, we enable clients to secure a place in their respective sector. Clients with limited financial means can utilize multimedia marketing to gain a competitive edge via the Internet. For more information, please visit

About Solos Endoscopy, Inc.

Solos Endoscopy, Inc. is a Boston, Massachusetts-based healthcare technology company, whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center or physician office. For additional information, visit

Safe Harbor: Forward-looking statements in this release are made pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence upon third-party suppliers, intellectual property rights and other risks.

Contact Information

  • Contact:
    Solos Endoscopy, Inc.
    Boston/Dedham Commerce Park
    65 Sprague Street
    Boston, MA 02136
    (800) 388-6445